Activated protein C alters cytosolic calcium flux in human brain endothelium via binding to endothelial protein C receptor and activation of protease activated receptor-1

Blood

Volumn 101, Issue 12, 2003, Pages 4797-4801

  Dömötör, Eszter ^b   Benzakour, Omar ^b   Griffin, John H ^b   Yule, David ^b   Fukudome, Kenji ^b   Zlokovic, Berislav V ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; CELL RECEPTOR; ENDOTHELIAL PROTEIN C RECEPTOR; ENZYME PRECURSOR; PROTEIN C; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 2; PROTEINASE ACTIVATED RECEPTOR 3; THAPSIGARGIN; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL MONITORING; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ENDOPLASMIC RETICULUM; ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME ACTIVATION; FLUOROMETRY; HUMAN; HUMAN CELL; MUTANT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 0038115229     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-12-3680     Document Type: Article

References (37)

1. Shibata M, Kumar SR, Amar A, et al. Antiinflammatory, antithrombotic, and neuroprotective effects of activated protein C in a murine model of focal ischemic stroke. Circulation. 2001;103:1799-1805.
2. Griffin JH, Zlokovic BV, Fernández JA. Activated protein C: potential therapy for severe sepsis, thrombosis, and stroke. Semin Hematol. 2002:39:197-205.
3. Mizutani A, Okajima K, Uchiba M, Noguchi T. Activated protein C reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation. Blood. 2000;95:3781-3787.
4. Bernard GR, Ely EW, Wright TJ, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699-709.
5. Folsom AR, Rosamond WD, Shahar E, et al. Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation. 1999;100:736-742.
6. Joyce DE, Gelbert L, Ciaccia A, DeHoff B, Grinnell BW. Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J Biol Chem. 2001;276:11199-11203.
7. Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science. 2002;296:1880-1882.
8. Vu TKH, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 1991;64:1057-1068.
9. Hwa JJ, Ghibaudi L, Williams P, et al. Evidence for the presence of a proteinase-activated receptor distinct from the thrombin receptor in vascular endothelial cells. Circ Res. 1996;78:581-588.
10. Böhm SK, Kong W, Brömme D, et al. Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochem J. 1996;314:1009-1016.
11. Bartha K, Dömötör E, Lanza F, Adam-Vizi V, Machovich R. Identification of thrombin receptors in rat brain capillary endothelial cells. J Cerebr Blood Flow Metabol. 2000;20:175-182.
12. Fukudome K, Kurosawa S, Stearns-Kurosawa DJ, He X, Rezaie AR, Esmon CT. The endothelial cell protein C receptor. J Biol Chem. 1996;271:17491-17498.
13. Stearns-Kurosawa DJ, Kurosawa S, Mollica JS, Ferrell GS, Esmon CT. The endothelial protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proc Natl Acad Sci U S A. 1996;93:10212-10216.
14. Ye X, Fukudome K, Tsuneyoshi N, et al. The endothelial cell protein C receptor (EPCR) functions as a primary receptor for protein C activation on endothelial cells in arteries, veins and capillaries. Biochem Biophys Res Comm. 1999;259:671-677.
15. Liaw PCY, Mather T, Oganesyan N, Ferrell GL, Esmon CT. Identification of the protein C/activated protein C binding sites on the endothelial cell protein C receptor. J Biol Chem. 2001;276:8364-8370.
16. Cheng T, Liu D, Griffin JH, et al. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective. Nat Med. 2003;9:338-342.
17. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature. 2000;14;407:258-264.
18. Loew D, Perrault C, Morales M, et al. Porteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry. Biochemistry. 2000;39:10812-10822.
19. Gale AJ, Sun X., Heeb MJ, Griffin JH. Nonenzymatic anticoagulant activity of the mutant serine protease Ser360Ala-activated protein C mediated by factor Va. Protein Sci. 1997;1:132-140.
20. Heeb MJ, Schwarz HP, White T, Lammle B, Berrettini M, Griffin JH. Immunoblotting studies of the molecular forms of protein C in plasma. Thromb Res. 1988;52:33-43.
21. Mackic JB, Stins M, McComb JG, et al. Human blood-brain barrier receptors for Alzheimer's amyloid-beta 1-40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J Clin Invest. 1998;102:734-743.
22. Grynkiewicz G, Poenie M, Tsien RY. A new generation of calcium indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440-3450.
23. Poenie M. Alteration of intracellular fura-2 fluorescence by viscosity: a simple correction. Cell Calcium. 1994;11:85-91.
24. 2- transport ATPases. J Membr Biol. 1994;141:1-6.
25. Abbott NJ, Revest PA. Control of brain endothelial permeability. Cerebrovasc Brain Metabol Rev. 1991;3:39-72.
26. Fleming I, Fisslthaler B, Busse R. Calcium signaling in endothelial cells involves activation of tyrosine kinases and leads to activation of mitogen-activated protein kinase. Circ Res. 1995;75:522-529.
27. Abbott NJ, Romero IA. Transporting therapeutics across the blood-brain barrier. Mol Med Today. 1996;2:106-113.
28. Bartus RT, Elliott P, Hayward N, Dean R, McEwen EL, Fisher SK. Permeability of the blood-brain barrier by the bradykinin agonist, RMP-7: evidence for a sensitive, auto-regulated, receptor-mediated system. Immunopharmacology. 1996;33:270-278.
29. 2+, phospholipase C and mitogen-activated protein kinase. Br J Pharmacol. 1997;122:935-941.
30. Boarder MR, Hourani SMO. The regulation of vascular function by P2 receptors: multiple sites and multiple receptors. Trends Pharmacol Sci. 1998;19:99-107.
31. DenkerBM, Nigam SK. Molecular structure and assembly of the tight junction. Am J Physiol. 1998;274:F1-9.
32. Abbott NJ. Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol. 2000;20:131-147.
33. Brown RC, Davis TP. Calcium modulation of adherens and tight junction function: a potential mechanism for blood-brain barrier disruption after stroke. Stroke. 2002:33:1706-1711.
34. Altrogge LM, Monard D. An assay for high-sensitivity detection of thrombin activity and determination of proteases activating or inactivating protease-activated receptors. Anal Biochem. 2000;277:33-45.
35. 2+ exchange and its implication for calcium homeostasis in primary cultured rat brain microvascular endothelial cells. J Physiol (Lond). 1999;515:147-155.
36. Chao TSO, Byron KL, Lee KM, Villereal M, Rosner MR. Activation of MAP kinases by calcium-dependent and calcium-independent pathways. J Biol Chem. 1992;267:19876-19883.
37. Benzakour O, Fernandez JA, Griffin JH, Zlokovic BZ. Activated protein C acts directly on human brain endothelial cells and is a potent mitogen on human brain vascular smooth muscle cells. 28th Int Stroke Conf Abstract: P89.